Jodi L Johnson

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Drug Administration

Systemic Lupus Erythematosus

Top Venues

Antibiotics (Basel, Switzerland)

The Journal of cell biology

Clinical, cosmetic and investigational dermatology

Pigment cell & melanoma research

This page only lists publications with an associated author ORCID identifier.

Publications

Hope E Burks, Jenny L Pokorny, Jennifer L Koetsier, Quinn R Roth-Carter, Christopher R Arnette, Pedram Gerami, John T Seykora, Jodi L Johnson, Ziyou Ren, Kathleen Janee Green
Melanoma cells repress Desmoglein 1 in keratinocytes to promote tumor cell migration. The Journal of cell biology 222 (11) (2023)
Ana Margarida Martins, Joana Marques Marto, Jodi L Johnson, Emmy M Graber
A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea. Antibiotics (Basel, Switzerland) 10 (7) (2021)
Christopher G Bunick, Jonette Keri, S Ken Tanaka, Nika Furey, Giovanni Damiani, Jodi L Johnson, Ayman Grada
Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation. Antibiotics (Basel, Switzerland) 10 (4) (2021)
Angela Yen Moore, James Q Del Rosso, Jodi L Johnson, Ayman Grada
Sarecycline: A Review of Preclinical and Clinical Evidence. Clinical, cosmetic and investigational dermatology 13 (2020)
Christopher R Arnette, Quinn R Roth-Carter, Jennifer L Koetsier, Joshua A Broussard, Hope E Burks, Kathleen Cheng, Christine Amadi, Pedram Gerami, Jodi L Johnson, Kathleen Janee Green
Keratinocyte cadherin desmoglein 1 controls melanocyte behavior through paracrine signaling. Pigment cell & melanoma research 33 (2) (2019)